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Caspase-3 cleavage of Salmonella type III secreted effector protein SifA is
required for localization of functional domains and bacterial dissemination
Samir Patela, Daniel M. Wallb, Antonio Castilloa, and Beth A. McCormicka
aDepartment of Microbiology and Physiological Systems, University of Massachusetts Medical School, Worcester, MA, USA; bInstitute of
Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK
ABSTRACT
SifA is a bi-functional Type III Secretion System (T3SS) effector protein that plays an important
role in Salmonella virulence. The N-terminal domain of SifA binds SifA-Kinesin-Interacting-
Protein (SKIP), and via an interaction with kinesin, forms tubular membrane extensions called
Sif filaments (Sifs) that emanate from the Salmonella Containing Vacuole (SCV). The C-terminal
domain of SifA harbors a WxxxE motif that functions to mimic active host cell GTPases. Taken
together, SifA functions in inducing endosomal tubulation in order to maintain the integrity of
the SCV and promote bacterial dissemination. Since SifA performs multiple, unrelated functions,
the objective of this study was to determine how each functional domain of SifA becomes
processed. Our work demonstrates that a linker region containing a caspase-3 cleavage motif
separates the two functional domains of SifA. To test the hypothesis that processing of SifA by
caspase-3 at this particular site is required for function and proper localization of the effector
protein domains, we developed two tracking methods to analyze the intracellular localization of
SifA. We first adapted a fluorescent tag called phiLOV that allowed for type-III secretion system
(T3SS) mediated delivery of SifA and observation of its intracellular colocalization with caspase-
3. Additionally, we created a dual-tagging strategy that permitted tracking of each of the SifA
functional domains following caspase-3 cleavage to different subcellular locations. The results of
this study reveal that caspase-3 cleavage of SifA is required for the proper localization of
functional domains and bacterial dissemination. Considering the importance of these events
in Salmonella pathogenesis, we conclude that caspase-3 cleavage of effector proteins is a more
broadly applicable effector processing mechanism utilized by Salmonella to invade and persist
during infection.
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Introduction
Salmonella enterica serovar Typhimurium
(S. Typhimurium) is a Gram-negative, faculta-
tive, intracellular anaerobe that causes gastro-
enteritis. In the United States, S. Typhimurium
is responsible for nearly 25% of all food-borne
infections and continues to be a major public
health and economic burden.1S. Typhimurium
infection in humans is typically acquired by
ingestion of contaminated food or water lead-
ing to acute gastroenteritis, and can also lead to
severe complications or death in persons at
risk.2 Salmonella species, like other Gram-nega-
tive pathogens, have a sophisticated virulence
mechanism called a type III secretion system
(T3SS), which is responsible for the delivery of
a series of bacterial effectors into host cells
aimed at reprogramming eukaryotic cell
functions.3–5 S. enterica use two distinct type
III T3SSs encoded on Salmonella pathogenicity
islands (SPIs)-1 and-2 to inject their arsenal of
effectors. In general, the SPI-1-encoded T3SS is
primarily required for the invasion of non-pha-
gocytic cells, where expression is induced by
the intestinal microenvironment, enabling
Salmonella to cross the epithelial gut barrier
and promote intestinal inflammation.
Subsequently, the SPI-2-encoded T3SS mediates
intracellular bacterial replication and is neces-
sary for the establishment of systemic disease.
The type III secreted effectors (T3SEs) consti-
tute a large and diverse group of virulence proteins
that mimic eukaryotic proteins in structure and
function. In fact, over 30 different effector proteins
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are delivered into host cells by S. Typhimurium
through both SPI-1 and SPI-2 T3SSs.6,7 A promi-
nent feature shared by bacterial effectors is their
modular architecture, which is often comprised of
well-defined regions that confer a subversive func-
tion. Strikingly, the distinct modules within an
effector often mediate very different, unrelated
functions, strongly suggesting that they evolved
independently of each other and subsequently
combined to form a chimeric protein.8,9
Chimerization is a common theme shared by
many effectors,10 and this forms the basis of a
provocative hypothesis termed ‘terminal reassort-
ment’, proposed by Guttman and colleagues to
explain the diversity of bacterial effectors.9 The
terminal reassorment tenet is substantiated by
their finding that 32% of all T3SE families contain
chimeric effectors, far greater than any other ana-
lyzed protein family. Additionally, other studies
suggest that terminal reassortment is important
for the evolution of these virulence proteins.8,9 In
keeping with this theory, we previously observed
that many T3SEs harbor a functional caspase-3
cleavage motif (DxxD) uniquely positioned at the
junction separating the two distinct functional
domains.11 This finding revealed that T3SEs had
evolved to use the host defense system in a manner
pivotal to the pathogenicity of the organism.11
More specifically, S. Typhimurium appears to
have evolved a mechanism to deliver effector pro-
teins in a precursor form to the host cell where
they are processed into independent functionally
active domains.
Although much attention has been given to iden-
tifying the functions of T3SEs, mechanisms under-
lying host mediated effector processing (e.g.,
cleavage) are far less appreciated. To further our
understanding in this regard, we had previously
examined at two SPI-1 effector proteins, SipA and
SopA, and found that caspase-3 processing was
necessary for the function of these T3SEs.11 In this
report, we chose to take a closer look at SPI-2, which
mediates the translocation across the vacuolar mem-
brane of a set of bacterial effector proteins that sup-
port collectively the intra-vacuolar replication. One
such SPI-2 effector protein SifA12 plays a significant
role in Salmonella virulence by maintaining the
integrity of the Salmonella-containing vacuole
(SCV),13 and hence promoting the formation of
tubular membranous structures connected to SCVs
that are named Salmonella-induced tubules (also
referred to as Sif filaments).14 Unique to this effector
protein, the N-terminal domain of SifA interacts
with the pleckstrin homology domain of the host
kinesin-binding protein SKIP, and the C-terminal
domain harbors a WxxxE motif that mimics the
active the form of Rho-GTPases. Cooperatively
these functional domains, along with another SPI-2
T3SE SseJ, promote host membrane tubulation.14
The resolution of the crystal structure and
domain function analysis of SifA has shown that
the protein is divided into two distinct major
domains14–16 separated by a potential caspase-3
cleavage site,11 suggesting the two domains of
SifA might act independently of each other upon
cleavage. Herein we characterize the structural
features of the caspase-3 cleavage motif in SifA,
and describe a new method of tracking T3SEs to
show that cleavage of SifA by caspase-3 is indeed
critical for proper localization of its functional
domains, and is essential for bacterial dissemina-
tion. Understanding how T3SEs are functionally
controlled through caspase-3 processing, will shed
new light concerning the co-evolutionary interplay
between S. Typhimurium and its host.
Materials and methods
Bacterial strains, plasmids, and growth
conditions
Wild type S. Typhimurium SL1344, and isogenic
mutants thereof (Table 1), were used throughout
this study. All cloning was carried out in
Escherichia coli strain BL21 DE3 (Invitrogen). All
bacterial strains were constructed and cultured in
LB as previously described,17 unless otherwise spe-
cified. Primers used for construction of bacterial
plasmids are listed in Table 2.
Table 1. Bacterial strains and plasmid constructs.
GST-SifA
This Paper based
on Ohlson 2008
GST-SifAcsm This Paper
ΔSifA This Paper
ΔSifA/pGST-SifA and ΔSifA/pGST-SifAcsm This Paper
ΔSifA/SifA-phiLOV This Paper
V5-SifA-HA, V5-SifA, SifA-HA, V5-SifAcsm-HA This Paper
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-GST-SifA
SifA was PCR-amplified from wild-type (WT) S.
Typhimurium (SL1344) using primers SP5 and
SP6. The PCR product was then digested, purified,
and ligated to the GST-containing vector, pGEX-
6p-1 (GE Healthcare), as described previously.14
-GST-SifAcsm
SifAcsm was synthetically generated and cloned
into pUCIDT-AMP by Integrated DNA
Technologies (IDT) using the same cloning sites
as GST-SifA. sifAcsm was then cloned into pGEX-
6p-1 and sequences were verified using the same
methods used for GST-SifA.
-ΔSifA
The ΔSifA mutant was constructed from SL1344
by deletion mutagenesis using a chloramphenicol
cassette as described by Datsenko and Wanner.18
Briefly, a chloramphenicol resistance cassette was
PCR amplified from the pKD3 plasmid using pri-
mers SP1 and SP2. The pKD3 PCR product was
then concentrated and transformed into electro-
competent SL1344 expressing the pKD46 plasmid.
The sifA deletion was sequence verified using SP3
and SP4 primers.
-ΔSifA/pGST-SifA and ΔSifA/pGST-SifAcsm
The ΔSifA/pGST-SifA and ΔSifA/pGST-SifAcsm
complemented strains were made using the ΔSifA
mutant. pGST-SifA and pGST-SifAcsm plasmid
DNA were transformed into the electrocompetent
ΔSifA strain of Salmonella. Transformants were
sequence verified using SP3 and SP4 primers.
-ΔSifA/SifA-phiLOV
SifA-phiLOV was made using pUC57-SipA-phiLOV.
sifA was PCR amplified from SL1344 using SP7 and
SP8 primers. These primers added a SacI and XhoI
site on the 5ʹ and 3ʹ ends of sifA, respectively. Since
sipA was cloned into pUC57-phiLOV using the same
cloning sites, the pUC57-SipA-phiLOV plasmid was
digested with SacI and XhoI (NEB) to remove sipA,
and then gel purified.19 The sifA PCR product was
similarly digested and purified and ligated to pUC57-
phiLOV before being transformed in the same man-
ner as pGST-SifA. Plasmid DNA was then isolated
from transformants that had ampicillin resistance and
transformed into electrocompetent ΔSifA.
-Single/dual tagged SifA constructs for lentiviral
transduction
V5-SifA-HA, V5-SifA, SifA-HA, and V5-SifAcsm-
HA constructs were generated and cloned into
pUC57 with AgeI and EcoRI cloning sites by
Genscript. Both V5 and HA are small ectopic
tags that can be visualized using fluorescent anti-
bodies. Plasmids were then digested with AgeI and
EcoRI, and cloned into pLVX-TetOne-Puromycin
and pLVX-TetOne-Blasticidin using the same
restriction sites.
SifA purification
A 10 mL overnight culture of Escherichia coli BL21
expressing pGST-SifA in LB/Ampicillin media was
back diluted 1:100 into a 1 L LB/Ampicillin. The
culture was grown at 37°C for 3.5 hr and then
induced with 1 mM IPTG at 22°C for 3 hr. The
bacteria were resuspended in GST Lysis Buffer
(25 mM Tris pH 8, 150 mM NaCl, 3 mM DTT,
and 1 mM PMSF) and then sonicated for 30 sec
Table 2. Primers used for construction of bacterial plasmids (5ʹ→ 3ʹ).
SP1 CCGATTACTATAGGGAATGGTTTTTTAAAAAGTGAAATCCTTACCAACTCGTGTAGGCTGGAGCTGCTTCG
SP2 AAAACAACATAAACAGCCGCTTTGTTGTTCTGAGCGAACGTGTAGCGTGGCATATGAATATCCTCCTTAGT
SP3 ATCCGCGGTAGTCCTTCTTT
SP4 CAGAGGATGGGGTGCTTTTA
SP5 GCGCGCGAATTCCCGATTACTATAGGGAATGGTTT
SP6 GCGCGCCTCGAGTTATAAAAAACAACATAAACAGCCGC
SP7 GCGCGCGAGCTCATGCCGATTACTATAGGGAATGGTTT
SP8 GCGCGCCTCGAGTAAAAAACAACATAAACAGCCGC
SP9 CGATCCCGCGAAATTAATACGACTC
SP10 CAAAAAACCCCTCAAGACCCGTTTA
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intervals 4 times. The lysate was then clarified at
14,000 rpm for 1 hr at 4 degrees Celsius. The
clarified lysate was then run through glutathione
sepharose beads in a column (GE Healthcare),
washed with 1 X phosphate buffered solution
(PBS), and then eluted using reduced glutathione
(GE Healthcare).
Caspase-3 cleavage assay
Purified GST-SifA and GST-SifAcsm were incu-
bated with 10U and 20U of active recombinant
human caspase-3 (BioVision) for 1 hr at 37°C.
The resulting products were then Western blotted
using Anti-GST antibody (GE Healthcare).
Densitometry analysis was performed using the
free online software FIJI.
Mouse dissemination and colonization
experiments (both oral and tail vein infection)
For intestinal colonization, mice were treated with
40 uL of 100 mg/mL streptomycin 24 hrs prior to
infection, as described previously.20 Mice were
then infected with 1 × 107 colony forming units
(CFUs) of each bacterial strain by oral gavage. At
48 hr post-infection (hpi) the liver and proximal
colon were harvested for dissemination analysis.
Dissemination analysis was completed by homo-
genizing the tissues and serial dilution plating. For
tail vein injection, mice were injected with 1 × 106
bacteria and dissemination analysis was again car-
ried out but at 24 hpi. Statistical analyses were
completed using an unpaired Student’s t test.
Generation of caspase-3 KO HeLa cells
The caspase-3 KO HeLa cells were generated
according to the Caspase-3 CRISPR/Cas9 construct
manufacturer’s instructions (Santa Cruz
Biotechnology). Briefly, 1µg of the Caspase-3
CRISPR/Cas9 plasmid and 1µg of the HDR plasmid
(contains puromycin resistance marker for selec-
tion) were incubated with Plasmid Transfection
Medium (Santa Cruz Biotechnology). Ten µL of
the UltraCruz Transfection Reagent (Santa Cruz
Biotechnology) was incubated with Plasmid
Transfection Medium. The solution containing the
plasmids and the solution containing the UltraCruz
Transfection Reagent were then combined and
incubated at room temperature for 20 min. After
incubation, the combined solution was added to
HeLa cells in fresh H1 media. H1 media was
replaced 24 hr later, and selection with H1 media
containing 2 µg/mL puromycin was started 72 hr
post-transfection. Cells were sub-cultured for
2 weeks before use in experiments.
Lentiviral transduction of WT and caspase-3 KO
HeLa cells
Six µg of each construct was cloned into pLVX-
TetOne-Puro (for WT HeLa cells) or pLVX-
TetOne-Blasticidin (for Caspase-3 KO HeLa cells),
4µg of a packaging plasmid psPAX2 and 2ug of an
envelope plasmid pMD2.G were added to Opti-MEM
media (Difco). Thirty-six µL of TransIT-293 transfec-
tion reagent was added to theOpti-MEMmixture and
incubated at room temperature for 30min. The trans-
fection mixture was then added dropwise to indivi-
dual 10 cm dishes of HEK293T cells. HEK293T cells
were plated at 6–8 x 106 in 8mLs of D10media (made
using 500 mL DMEM, 10% FBS, 5 mL Pen/Strep,
10 mL L- glutamine, and 50 µL plasmocin,
Invivogen).
After 48 hr, the supernatant containing the
virus from each plate was collected and added
dropwise to WT HeLa cells (constructs in pLVX-
TetOne-Puro) or caspase-3 KO HeLa cells (con-
structs in pLVX-TetOne-Blasticidin) that were
>60% confluent. Both WT and caspase-3 KO
HeLa cells were incubated with virus overnight,
and then selected using puromycin or blasticidin,
respectively.
In vitro infection experiments
A 3 mL overnight LB culture of SL1344 or LB/
Ampicillin cultures of ΔSifA/pSifA-phiLOV were
back-diluted 1:5 into 10 mL LB broth or LB/
Ampicillin/1 mM IPTG, respectively, and grown at
37°C for 1hr. Fifty µL of this culture was then added to
1mL H1 media, and 200 µL per well was used for
infection of WT and caspase-3 KO HeLa cells.
Following a 1 hr infection, the cells were incubated
with H1 media containing 50 µg/mL gentamicin for
1 hr, before incubation with H1 media containing
10 µg/mL gentamicin until 1, 2, 4, 8, and/or 10 hpi.
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Cells were fixed and permeabilized in 1% bovine
serum albumin (BSA)/0.2% saponin then stained
using Image-iT LIVE Caspase-3 Detection Kit
(ThermoFisher) for SifA-phiLOV/Caspase-3 colocali-
zation experiements. For dual-tagged SifA constructs,
cells were stained using anti-V5 (Abcam) and anti-
HA primary antibodies (Santa Cruz), and goat anti-
rabbit Alexa Fluor 488 and goat anti-mouse Alexa
Fluor 568 secondary antibodies (Invitrogen). Cells
were then visualized using a 63X objective lens on a
confocal microscope Leica SP5 confocal microscope.
Colocalization data was determined using the Coloc 2
tool in the free online software FIJI. The Mander’s
coefficient was the selected output, which is a pixel
intensity spatial correlation analysis.
Results
Structural features of the caspase-3 motif in S.
Typhimurium T3SE SifA
Given that the resolution of the crystal structure
and domain function analysis of SifA has shown
that the protein is divided into two distinct major
domains14–16 separated by a potential caspase-3
cleavage site,11 we investigated the structural fea-
tures of the caspase-3 cleavage motifs by in silico
modeling of the crystallized caspase-3
substrate.14,16 Protein sequences were retrieved
from the NCBI protein database, screened for cas-
pase-3 motifs, and then analyzed in the web server
Phyre2 for the identification of structural homo-
logues. We found that the caspase-3 motif is sur-
rounded by hydrophilic residues, exposed at the
surface, and localized in coiled regions of proteins
(Figure 1). Additionally, we studied the frequency
of the DxxD site by analyzing the residue down-
stream of the caspase-3 cutting site (DxxD-x) in 33
known caspase-3 substrates.21 Of these residues,
serine, glycine, and asparagine (all hydrophilic/
polar residues) are most frequently located down-
stream of the caspase-3 cleavage site; serine was
found 13 times, glycine 10 times, and asparagine 4
times and is consistent with our observation of the
CASP3 motif being surrounded by hydrophilic
residues.
SifA harbors a functionally active caspase-3
cleavage site
SifA is a SPI-2 S. Typhimurium effector protein
necessary for intracellular survival. Based on the
structural data as shown in Figure 1, as well as the
observation that each of the SifA domains function
independently,14,16 we next sought to determine
whether the caspase-3 motif of SifA (DRPD) is
SifA 
coil 
surface 
& exposed 
Polar 
domain 
DRPD 
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a b
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Figure 1. The structural characteristics of the caspase-3 motif (are conserved in evolution).
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functionally active. To do this we PCR amplified
SifA from SL1344 and cloned it into pGEX-6p-1
(GE Healthcare), which adds an N-terminal GST
tag to SifA that has been previously used to purify
SifA protein using a glutathione sepharose matrix.-
14 We found that that exogenous addition of
purified fractions of SifA (5µg) with commercially
obtained active caspase-3 enzyme (10U and 20U)
(Biovision) resulted in the cleavage of this effector
protein at the expected site as evidenced by a
decrease in the amount of SifA protein and con-
comitant increase in degradation products
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Figure 2. SifA harbors a functionally active caspase-3 cleavage site. (a) Purified fractions of SifA and SifAcsm (5µg) were incubated
with 10 units or 20 units of human recombinant caspase-3 (Biovision) for 1 hr at 37 ºC. Each sample was then Western blotted using
an Anti-GST primary antibody (GE Healthcare) at 1:20,000 and Donkey anti-Goat IgG HRP secondary antibody (Santa Cruz) at 1:5,000.
The cleavage products for both SifA and SifAcsm were visualized using coomassie blue staining (BioRad). SifA protein, but not
SifAcsm protein, was cleaved by caspase-3 in a concentration dependent manner. (b) Densitometry of Western Blot in (a), SifA
(Black), SifAcsm (Red), Cleavage Product 1 (Green), and Cleavage Product 2 (Blue). SifA, but not SifAcsm, displays a caspase-3
concentration dependent decrease, which coincides with an increase in both Cleavage Product 1 and Cleavage Product 2.
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(Figure 2(a,b)). Additionally, a single amino acid
substitution in the caspase-3 recognition site is
known to render substrates insensitive to cas-
pase-3. Thus, we altered the caspase-3 site
(DRPD) by one amino acid to DRPA (refer to
methods). The plasmid bearing the mutant clone
was sequence confirmed and named pSifAcsm (for
SifA caspase site mutant). Such mutation of the
caspase-3 site by one amino acid to alanine ren-
dered SifA insensitive to caspase-3 cleavage
(Figure 2(a,b)).
SifA colocalizes with caspase-3 during infection
To more deeply understand how the processing
of SifA occurs through caspase-3 cleavage, we
used the small fluorescent phiLOV tag to deter-
mine the extent to which we can observe cas-
pase-3 and SifA colocalizing during an in vitro
infection. This method does not interfere with
secretion kinetics of the effector through the
T3SS and can be used to examine de novo
expression of T3SEs in vitro and in vivo.19,22,23
As shown in Figure 3(a), following infection of
HeLa cells with Salmonella, SifA-phiLOV colo-
calizes with caspase-3 beginning at 2 hpi (seen
by yellow), with colocalization continuing
through at 4 hpi After 4 hr, colocalization was
found to decrease (Figure 3(a,b)). Our prior
studies found that increased caspase-3 activa-
tion occurs in SL1344-infected intestinal epithe-
lial cells over the first 5 hr of infection, with the
effector protein SipA playing a central role11;
thus such co-localization of SifA with caspase-3
is consistent with the timing of these events.
Moreover, consistent with our previous
findings11, we show that early after Salmonella
infection of epithelial cells this pathogen acti-
vates caspase-3, without inducing apoptosis as
determined by a Western blot for activated cas-
pase-3 (Figure 3(c)) and Annexin V staining
(Figure 3(d)); as shown, infection with
Salmonella expressing SifA-phiLOV results in
an increase in activated caspase-3 expression
(via the function of SipA), but no significant
difference in Annexin V positive cells in com-
parison to uninfected HeLa cells.
Caspase-3 cleavage of SifA is necessary for
dissemination
SifA plays a key role in maintaining the integrity
of the Salmonella-containing vacuole (SCV)13,
through the formation of tubular membranous
structures connected to SCVs named Salmonella-
induced tubules. Because the formation of such
tubules is an essential virulence requirement for
intracellular replication in macrophages, and
hence contributes to the ability of Salmonella to
successfully disseminate to extraintestinal organs
(i.e., liver and spleen), we next sought to deter-
mine whether caspase-3 cleavage of SifA is neces-
sary for Salmonella dissemination. Using the
murine model of Salmonella-induced enteritis, as
described in the Methods, we found that consis-
tent with prior reports,24 deletion of the sifA gene
from S. Typhimurium results in a 1 log decrease
in dissemination of bacteria to the liver
(Figure 4(a)).
Next, we complimented this SifA deletion strain
of Salmonella with two plasmids; one expressing
SifA and the other SifAcsm. We reasoned that if
cleavage of SifA at the caspase-3 cleavage site was a
critical event required for dissemination, we would
expect to see the SifAcsm phenocopy the SifA
deletion strain. As shown in Figure 4(a), we
found that when the caspase-3 cleavage site is
mutated, we indeed observed a similar 1 log
decrease in dissemination to the liver. However,
when the SifA deletion strain is complemented
with a plasmid containing SifA, there was a rescue
of the phenotype to near wild-type levels of dis-
semination to the liver.
While all strains colonized the large intestine
to similar levels (Figure 4(b)), we needed to rule
out the possibility that the decrease in dissemi-
nation observed for the SifAcsm mutant strain
resulted from a defect in the ability to dissemi-
nate via the blood to the liver. We therefore
delivered the Salmonella strains systemically
through tail vein injection, and found that both
the ΔSifA strain as well as the SifAcsm strain,
showed similar levels of bacterial load in the
liver as compared to the wild type and SifA-
complemented strain (Figure 4(c)). Given that
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the SifAcsm strain does not demonstrate an
impairment in either the ability to colonize the
intestine or reach the liver when delivered sys-
temically suggests that the defect observed
results from a failure to disseminate from the
intestine.
Subcellular localization of SifA functional
domains is dependent upon caspase-3 cleavage
Although we have been able to link SifA function to
cleavage at the caspase-3 cleavage site, we next sought
to determine whether the each of the SifA functional
domains could be sub-cellularly tracked following
Figure 3. SifA colocalizes with caspase-3 during infection. (a) HeLa cells were infected with Δ SifA/pSifA-phiLOV, fixed at 2, 4, and
8 hrs post-infection, stained with Image-iT LIVE Caspase-3 Detection Kit (ThermoFisher) and visualized using fluorescent confocal
microscopy. Caspase-3 (Red) and SifA-phiLOV (Green) can be seen colocalizing at 2 hrs post-infection (Yellow; bottom, left panel),
with colocalization decreasing through 8 hrs. post-infection (bottom, bottom middle, and bottom right panels). (b) Colocalization of
SifA-phiLOV and caspase-3 quantified using FIJI Software. (c) Western Blot for activated-Caspase-3. HeLa cells were infected with
indicated strains, lysed, and analyzed for activated caspase-3 expression. Protein concentration was determined using a Bradford
Assay to ensure equal amounts of protein were loaded into each well (d) Annexin V Staining Assay. HeLa cells were infected with
indicated strains, trypsinized, and stained with Annexin V. Flow cytometric analysis was then completed on a MACSQuant Analyzer
to determine the number of Annexin positive cells. In comparison to the negative control (uninfected), HeLa cells only showed a
significant increase in Annexin V positive cells with the use of 10µM of staurosporine. HeLa cells infected with WT-SL1344, ΔSifA, and
ΔSifA/pSifA-phiLOV all do not exhibit a significant change in Annexin V positive cells in comparison to negative control (uninfected).
P Values (statistics calculated using unpaired Student’s t test): NS, not significant; *P < 0.05. Experiments were performed at least
three times using cells of different passage.
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caspase-3 cleavage. SifA is ideal for addressing this
question given that the N-terminal domain of SifA
interacts with the pleckstrin homology domain of the
host kinesin-binding protein SKIP, and the
C-terminal domain harbors a WxxxE motif that
mimics the active the form of Rho-GTPases. If cas-
pase-3 cleavage is necessary for SifA domain sub-
cellular localization, then each of the functional
domains would remain in the perinuclear region of
the cell, where the SCV resides, until after its interac-
tion with caspase-3. Then following caspase-3 clea-
vage, the individual functional domains would move
to distinct subcellular locations to perform their func-
tions. To this end, we designed dual-tagged V5-SifA-
HA and dual-tagged V5-SifAcsm-HA (Figure 5(a)),
allowing both red (V5) and green (HA) probes to be
displayed on a single effector. In addition to the full-
length protein, we also designed the individual
domains (N and C terminal domain) with a single
tag; – V5-SifA (green) and SifA-HA (red).
The benefit of using these constructs is that they
permit us to directly investigate the involvement of
the caspase-3 motif in SifA domain localization.
The V5-SifA-HA and V5-SifAcsm-HA constructs
can therefore be used to determine where each
domain localizes during infection, and if the
domain localization is dependent on caspase-3
cleavage. Additionally, the V5-SifA and SifA-HA
individual domain constructs can be used in
combination with caspase-3 KO HeLa cells to
determine if we restore domain localization when
we use individual domains that resemble their
post-caspase-3 cleavage form. Two of these con-
structs (V5-SifA-HA and V5-SifAcsm-HA) were
transduced into wild-type Hela cells using lenti-
viral transduction. The plasmids used also had an
inducible promoter, which allowed us to control
expression of all four constructs.
In order to stimulate caspase-3 activation typi-
cal of Salmonella infection, we infected the HeLa
cells transduced with all four constructs with wild-
type Salmonella, and then looked for the redistri-
bution of each of the functional domains at 1 and
10 hpi using immunofluorescent confocal micro-
scopy. Maximum Sif filament formation has been
observed previously between 8 and 10 hpi (25,26;
supplementary Figure 1). Since we found that SifA
colocalizes with caspase-3 at 2 hpi (Figure 2), we
included this earlier point (1 hr) to determine the
extent to which subcellular localizations change
following the interaction of the SifA with cas-
pase-3.
At 1 hpi (prior to caspase-3 activation), we
observe both SifA domains located in the perinuc-
lear region for both V5-SifA-HA and V5-SifAcsm-
HA (Figure 5(b), top left panel, Figure 5(c)).
However, following interaction with caspase-3 at
2 hpi, the N-terminal domain of V5-SifA-HA
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Figure 4. Caspase-3 cleavage of SifA is necessary for dissemination. (a) Mice were infected by oral gavage and livers were harvested
48 hrs. post-infection. Bacterial burdens were determined by homogenizing the livers and serial dilution plating. ΔSifA and ΔSifA/
pSifAcsm exhibit over 1 log decrease in bacterial burden in the liver. This decrease is restored upon complementation with pSifA.
Results are averages of 6 mice per group ± SD. B.) Mice were infected by oral gavage and proximal colon samples were taken 48 hr
post-infection. Bacterial burdens were determined similarly to (a). Results are averages of 6 mice per group +/- SD. ΔSifA, ΔSifA/
pSifA, and ΔSifA/pSifAcsm do not exhibit any significant defects in colonization of the proximal colon in comparison to WT-SL1344.
C.) Mice were infected via the tail vein, and livers were harvested 24 hr post-infection. Bacterial burden was determined similar to (a).
In comparison to WT-SL1344, ΔSifA, ΔSifA/pSifA, and ΔSifA/pSifAcsm all show similar levels of bacteria in the liver. P Values (statistics
calculated using unpaired Student’s t test): NS, not significant; *P < 0.05. Data shown are representative of at least three
independent experiments.
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begins to branch out from the perinuclear region
towards the extremities of the cell and continues to
spread throughout the cell at 10 hpi. The role of
caspase-3 processing in the domain localization of
V5-SifA-HA domains is further supported by the
profound decrease in colocalization of the SifA
domains at 10 hpi (Figure 5(b,c)). Additionally,
we observed a significant increase in the relative
distance of the N-terminal domain from the
nucleus for V5-SifA-HA at 10 hpi relative to 1
hpi (Figure 5(d)). We also observed this distance
to be markedly larger when the caspase-3 site was
intact, as evidenced by the significant difference at
10 hpi between V5-SifA-HA and V5-SifAcsm-HA
(Figure 5(d)). This result is consistent with current
literature indicating that the N-terminal domain of
SifA binds to a protein called SKIP, and then
forms Sif filaments via an interaction with
kinesin.14 Such Sif filaments are tubular membrane
extensions that emanate from the SCV, which is
located in the perinuclear region, towards the
outer part of the cell. Considering the localization
of the N-terminal domain for V5-SifA-HA, our
results are in line with current understanding of
SifA’s role in Sif filament formation.
Since the C-terminal domain of SifA mimics host
cell GTPases, and these host cell GTPases function in
a variety of roles, including cellular division and actin
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Figure 5. Subcellular localization of SifA functional domains is dependent upon caspase-3 cleavage. (a) Schematic depicting the
dual-tagging strategy for SifA. The V5 tag (green) is used on the N-terminus and the HA tag (red) is used on the C-terminus. (b) Wild-
type HeLa cells containing either V5-SifA-HA or V5-SifAcsm-HA were infected with WT-SL1344. The cells were fixed and stained (refer
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post-infection (follow localization of green V5 tag from 1 – 10 hr post-infection), and the C-terminus of SifA remains in the
perinuclear region for all time points following infection (red). When the caspase-3 cleavage site is mutated (V5-SifAcsm-HA), both
domains (red and green) are observed in the perinuclear region at all time points following infection. Experiments were performed
at least three times using cells of different passage. (c) Colocalization of the SifA N-terminal and C-terminal domains following
caspase-3 cleavage quantified using FIJI Software. (d) Relative distance (measured using a micron scale) of the distance travelled by
the N-terminal domain in both V5-SifA-HA and V5-SifAcsm-HA at 1 and 10 hrs. post-infection. P Values (statistics calculated using
unpaired Student’s t test): NS, not significant; **** P < 0.0001.
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cytoskeletal rearrangements, it is difficult to predict
where the C-terminal domain of SifA would localize
during Salmonella infection.27–29 Furthermore, the
C-terminal domain of SifA also contains a CaaX
motif. The CaaX motif is prenylated by the geranyl-
geranyl transferase PGGT-1, which is a process that
has been shown to facilitate attachment to cellular
membranes.30 On the balance of these reports, it
would be feasible to observe the C-terminal domain
in the perinuclear region at the SCV membrane, the
outer cell membrane, or both. However, as shown in
Figures 5(b) and 6(a), the C terminal of SifA appears
to remain primarily in the perinuclear region even
after interaction with caspase-3 at the 2 hr time point,
indicating the C-terminal domain of SifA likely
remains at the SCV membrane through the 10 hpi
time point.
We next determined the extent to which the cas-
pase-3 site in SifA plays a role in the localization
events we observed with V5-SifA-HA. To do this we
used the V5-SifAcsm-HA construct and found that
both of the functional domains of this strain remained
in the perinuclear region for all time points following
infection (Figure 5(b)). Additionally, we did not
observe a similar decrease in V5-SifAcsm-HAdomain
colocalization as observed with V5-SifA-HA (Figure 5
(c)). This result suggests that processing of SifA at the
caspase-3 site is essential for proper localization of
each of the SifA domains, and further infers that the
C-terminal domain appears to perform its “GTPase
mimicry” function in the perinuclear region after it’s
interaction with caspase-3. Nonetheless, further stu-
dies are required to discern whether the C-terminal
domain of SifA is indeed functionally active at this
location.
Activated individual SifA domains restore SifA
domain localization in caspase-3 KO cells
To further confirm the role of caspase-3 in the
localization of the SifA functional domains, we
generated caspase-3 KO HeLa cells using
CRISPR/Cas9 (refer to Methods). Additionally,
we designed the V5-SifA and SifA-HA constructs
containing individual domains (without the cas-
pase-3 site) to assess whether we could restore
localization each SifA functional domain by using
a form of each domain that resembles their post-
caspase-3 cleavage structure. V5-SifA-HA, V5-SifA
and SifA-HA were transduced into caspase-3 KO
HeLa cells in the exact same manner as they were
transduced into wild-type HeLa cells. As shown in
Figure 6(a), both domains of V5-SifA-HA remain
in the perinuclear region in the caspase-3 KO cells
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methods) at 1 and 8 hr post-infection. Without caspase-3, both domains of V5-SifA-HA remain in the perinuclear region at all
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for all time points following infection, phenocopy-
ing what we see in V5-SifAcsm-HA in wild-type
HeLa cells. When we use the post-caspase-3 clea-
vage form of each functional domain (V5-SifA and
SifA-HA), we restore the domain localization we
observed for V5-SifA-HA in wild-type HeLa cells,
further implying that caspase-3 plays a pivotal role
in the functional domain localization of SifA
(Figure 6(a)). Although SifA-HA resembles the
post-caspase-3 cleavage form of the SifA
C-terminal domain, the relative distance from the
nucleus does not change following infection as it
does for V5-SifA (Figure 6(b)). These results agree
with what is observed in Figure 5 for V5-SifA-HA
in wild-type HeLa cells, indicating the perinuclear
region of the HeLa cell is where the C-terminal
domain of SifA is inferred to perform its function.
Discussion
In silico modeling of the SifA caspase-3 motif at the
structural level revealed that this motif is sur-
rounded by hydrophilic residues, exposed at the
surface, and localized in coiled regions of proteins.
This finding is consistent with two other crystal-
lized structural homolog proteins of Salmonella
effectors (SopA and SptP) that we examined
(Supplementary Figures 2, and 3). This informa-
tion coupled to the known structural data of
SifA,14 suggested that cleavage of the caspase-3
motif in this effector divides this protein into an
interacting partner for the host protein SKIP
(N-terminal) and a member of the WxxxE family
of proteins with GTPase mimicry function (C-
terminal). We further report that cleavage of SifA
by caspase-3 is indeed critical for proper localiza-
tion of its functional domains, and is essential for
bacterial dissemination from the intestine. Such
data are consistent with prior evidence that each
of these domains can function independently,14
and is also in step with recent findings that SifA
can be split into two functional domains.16 Our
demonstration that caspase-3 cleavage of SifA is
required for bacterial dissemination, adds to the
emerging concept that caspase-3 sites are present
and functionally active in T3SE. Such processing
has been described for Salmonella invasion
(SipA),31 ubiquitination (SopA),31 and now in
this report for SCV maintenance and bacterial
dissemination (SifA), implying that caspase-3 clea-
vage may have a broad impact on the bacteria’s
ability to both invade and persist during infection.
Although we have previously shown that the
Salmonella T3SE, SipA, induces increased cas-
pase-3 activity upon S. Typhimurium infection,
such activation remains insufficient to induce the
signatures of apoptotic cell death (31, and this
report). Thus, our data suggest that SipA is not
only critical in inducing its own proteolytic clea-
vage but also that of other effectors such as SifA
via its role in caspase-3 activation. This idea is
consistent with our prior observations that
Salmonella is significantly less virulent in cas-
pase-3 knockout (CASP3−/-) mice and Salmonella
invasiveness in bone-marrow-derived macro-
phages from CASP3−/- mice is profoundly
reduced. 31 Moreover, in Salmonella strains lack-
ing SipA, it has been previously described that SifA
and SCVs are incorrectly positioned in the cell32
and in a manner shown herein, since the function
of SifA depends on activation by caspase-3.
Method development for dual-tagging effectors
permitted the tracking of effector proteins that also
reflects the timeline of effector protein activation
and localization during Salmonella infection.
Unlike other strategies, this method does not rely
on the T3SS secretion system for delivery of effector
proteins, avoiding any complications associated
with effector protein secretion kinetics or lack of
secretion signals. The benefit to using this method
is that it allows for the simultaneous tracking of
domain localization and activation. One potential
limitation to this method, however, is that it may be
difficult to determine activation of T3SE domains if
the localization does not change upon processing.
For example, the subcellular localization of the
N-terminal domain of SifA changes upon activa-
tion, whereas the C-terminal domain remains in the
perinuclear region (Figures 5 and 6). Although we
speculate the C-terminal domain is active, addi-
tional experimentation will be required to deter-
mine if this is indeed the case. Nevertheless, dual-
tagging of SifA demonstrated for the first time that
the individual domains of SifA have different sub-
cellular localizations. Additionally, the results from
our dual tagging method, in conjunction with the
findings of32 suggest that the C-terminal domain
alone may be acting to maintain the SCV in the
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perinuclear region, though further testing of this
hypothesis is required to determine if this is indeed
the case. Moreover, as Reinicke and colleagues
demonstrated in,30 the process termed prenylation
occurs at theCAAXmotif in the C-terminal domain
of SifA, which is a process important for membrane
association. Taking into account the localization of
the C-terminal domain determined in this study
and the perinuclear localization of the SCV deter-
mined in 32, the prenylation of the C-terminal
domain may be required for interaction with the
SCV membrane in the perinuclear region, although
further studies would be required to determine if
this is true.
Our prior studies revealed that S. Typhimurium
T3SEs evolved the ability to use host enzymes, such as
caspase-3 to activate themselves, displaying a high
degree of co-evolution.31 We speculate that the clea-
vage motifs of T3SEs have evolved over time and have
targeted their cleavage and activation via different
host enzymes depending on the host and cell type
infected.33 SipA, the first T3SE delivered into intest-
inal epithelial cells during infection is an excellent
example of the evolution of a T3SE in response to
selective pressures at the host-pathogen interface.
With type III secretion requiring the delivery of a
number of effectors rapidly over a short span of
time, the formation of a chimeric effector with a
lone signal sequence and requiring just a single cha-
perone, greatly reduces the workload at the T3SS
interface.
The relationship between bacterial effectors and
the activation of caspase-3 is an area of increasing
interest. While the outcome of such rearrange-
ments results in independently functional domains
coming together as one effector, this also creates a
unique challenge in separation of the domains
upon host cell delivery to ensure their correct
location and function. It is now understood that
caspase-3 is constantly present in the cell at levels
below those required to induce apoptosis19, sug-
gesting that caspase-3 processing of effectors likely
occurs throughout the cell rather than being
dependent on contact merely at the cell surface
or within the cytosol. Moreover, the interaction
between effector proteins and caspase-3 may play
a role in preventing caspase-3 from performing
other important functions during infection, as
has been described during Yersinia infection.34
Caspase-3 activation during bacterial infection
is also likely a common by-product of the co-
evolution of bacterial-host interactions, perhaps
precipitated by the stress placed on host cells dur-
ing invasion.35–39 In addition to non-specific or
indirect activation of caspase-3, bacterial effectors
are also able to promote caspase-3 activation
through subtle changes within cellular pathways
or even through direct interaction with the
enzyme. The outcome for the pathogenic intruder,
such as S. Typhimurium is often an increase in
infectivity rather than a clearing of the infection as
expected by the conventional understanding of the
protective role of apoptosis.
The study herein therefore supports the concept
that that caspase-3 cleavage of T3SS secreted effec-
tors represents a common mechanism by which
effector functions are regulated in host cells.
Understanding of this biological phenomenon as
well as advancing methods to interrogate T3SE func-
tion inside host cells will allow us to dissect specific
aspects of Salmonella-host interactions that have yet
to be documented, and in general could have broad
impact on the field of bacterial pathogenesis.
The structural features of the caspase-3 motif
found in the Salmonella effector protein SifA (PDB
ID 3CXB). Protein structures are displayed as car-
toon (Panels a and b), surface (Panel c), and spheres
(Panel c). Panel (a) shows protein structures colored
with the spectrum color set of PyMOL to display the
different protein domains, α-helixes, β-sheets, and
coil regions. In Panels (b) and (c), the location of the
caspase-3 motif is colored in red, whereas in Panel
(d) in yellow. In Panel (d), polar residues are colored
in pink and hydrophobic in grey. DRPD, DVHD,
and DGQD are putative caspase-3 motifs. PDB;
Protein data bank. SifA: Confidence 100%; Identity
79%; Coverage 90%.
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